Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
Pawlyn, C, Bright, M D, Buros, A F, Stein, C K, Walters, Z, Aronson, L I, Mirabella, F, Jones, J R, Kaiser, M F, Walker, B A, Jackson, G H, Clarke, P A, Bergsagel, P L, Workman, P, Chesi, M, Morgan, G J, Davies, F E
Published in Blood cancer journal (New York) (31.03.2017)
Published in Blood cancer journal (New York) (31.03.2017)
Get full text
Journal Article